Anticoagulation by Ancrod for Haemodialysis

Hall, G. H.; Holman, Hazel M.; Webster, A. D. B.
December 1970
British Medical Journal;12/5/1970, Vol. 4 Issue 5735, p591
Academic Journal
No abstract available.


Related Articles

  • ancrod.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p114 

    A definition of the term "ancrod," which refers to an enzyme purified from the venom of a Malayan pit viper and used as an anticoagulant, is presented.

  • VIPER VENOM FOR STROKE. Roblin, Andrew // Prevention;May89, Vol. 41 Issue 5, p16 

    Reports on the use of ancrod, an ingredient in venom from Malayan pit vipers, to treat heart attacks and to help stroke patients. Prevention of damage done by ischemic strokes by ancrod; Anticoagulant effects of snake venom which are deadly when administered in a large dose; Drug's dissolution...

  • ancrod.  // Taber's Cyclopedic Medical Dictionary;2005, p104 

    A definition of the medical term "ancrod" is presented. Ancrod refers to an enzyme purified from the venom of a Malayan pit viper and used as an anticoagulant. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The pronunciation of the term is also...

  • Co-overexpression of PpPDI Enhances Secretion of Ancrod in Pichia pastoris. Shou-Tao Zhang; Hui-Min Fang; Li Zhao; Qing-Nan Tian; Yun-Fei Qin; Ping Lu; San-Jun Chen; Zhen-Xia Bao; Feng Liang // Applied Biochemistry & Biotechnology;Aug2011, Vol. 164 Issue 7, p1037 

    ncrod, a serine protease purified from the venom of Agkistrodon rhodostoma, is highly specific for fibrinogen. It causes anticoagulation by defibrinogenation and has been used as a therapeutic anticoagulant for the treatment of moderate to severe forms of peripheral arterial circulatory...

  • Reversing the effects of stroke.  // New York Amsterdam News;02/11/99, Vol. 99 Issue 7, p43 

    Discloses the results of a clinical trial examining the effects of Ancrod, an experimental stroke drug derived from the venom of a pit viper snake. Presentation of the study at the 24th American Heart Association International Conference on Stroke and Cerebral Circulation; Percentage of...

  • Heparin.  // Reactions Weekly;10/20/2012, Issue 1424, p29 

    The article describes the case of two patients who developed heparin-induced thrombocytopenia during haemodialysis using heparin anticoagulation.

  • Should we use anticoagulant lock for short-term haemodialysis catheter in the ICU? Soubirou, Jean-François; Commereuc, Morgane; Kofman, Tomek; Constan, Adrien; Bourgeon-Ghittori, Irma; Schortgen, Frédérique // Intensive Care Medicine;Jun2014, Vol. 40 Issue 6, p912 

    A letter to the editor about the use of anticoagulant lock for short-term haemodialysis catheter in an intensive care unit (ICU) is presented.

  • Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Kozik-Jaromin, Justyna; Nier, Volker; Heemann, Uwe; Kreymann, Bernhard; Böhler, Joachim // Nephrology Dialysis Transplantation;Jul2009, Vol. 24 Issue 7, p2244 

    Background. Regional citrate anticoagulation is a very effective anticoagulation method for haemodialysis. However, it is not widely used, primarily due to the risk of hypocalcaemia. We studied citrate and calcium kinetics to better understand safety aspects of this anticoagulation method.

  • Anticoagulation and dialysis access practice in home haemodialysis in the UK. Breen, Cormac // Nephrology Dialysis Transplantation;Dec2011 Supplement 3, Vol. 4 Issue suppl_3, piii19 

    Anticoagulation is an important component of haemodialysis treatment in all settings. The therapeutic options available for anticoagulation of home haemodialysis are similar to those for haemodialysis in other settings. However, dialysis sessions with a wide range of treatment durations are...

  • Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply? Sisu, Roxana // Maedica - a Journal of Clinical Medicine;2007, Vol. 2 Issue 3, p261 

    The article presents a study on the role of anticoagulation guidelines in the atrial fibrillation (AF) in haemodialysis patients. The risk of hemorrhage due to vessel and platelet abnormalities associated with abnormal platelet adhesion and aggregation mechanisms are very high in haemodialysis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics